Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
437.40
-4.00 (-0.91%)
Aug 29, 2025, 4:59 PM CET

Zealand Pharma Revenue

Zealand Pharma had revenue of 9.09B DKK in the quarter ending June 30, 2025, with 26,527.65% growth. This brings the company's revenue in the last twelve months to 9.11B, up 2,375.69% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.

Revenue (ttm)
9.11B
Revenue Growth
+2,375.69%
P/S Ratio
3.38
Revenue / Employee
21.49M
Employees
335
Market Cap
30.78B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202462.69M-280.10M-81.71%
Dec 31, 2023342.79M238.80M229.65%
Dec 31, 2022103.99M-4.56M-4.20%
Dec 31, 2021108.55M-83.46M-43.47%
Dec 31, 2020192.00M150.67M364.52%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novo Nordisk311.94B
Coloplast27.87B
Genmab23.16B
Demant22.59B
ALK-Abelló5.86B
H. Lundbeck23.52B
Ambu A/S5.96B
Bavarian Nordic6.46B
Revenue Rankings